Exelon (NASDAQ:EXC – Free Report) had its target price upped by Scotiabank from $40.00 to $42.00 in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a sector perform rating on the stock.
A number of other equities research analysts have also recently issued reports on the stock. Morgan Stanley lowered their target price on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a report on Friday, November 22nd. UBS Group upped their price target on Exelon from $40.00 to $43.00 and gave the company a “neutral” rating in a research report on Friday, September 20th. Barclays raised their price objective on shares of Exelon from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. Finally, Jefferies Financial Group started coverage on shares of Exelon in a report on Thursday, September 19th. They set a “buy” rating and a $46.00 target price on the stock. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, Exelon has an average rating of “Hold” and an average target price of $41.42.
Check Out Our Latest Analysis on EXC
Exelon Trading Up 0.1 %
Exelon (NASDAQ:EXC – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.04. The firm had revenue of $6.15 billion during the quarter, compared to the consensus estimate of $5.85 billion. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The company’s revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.67 EPS. Equities research analysts predict that Exelon will post 2.45 EPS for the current year.
Exelon Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Monday, November 11th were paid a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 4.12%. The ex-dividend date was Friday, November 8th. Exelon’s dividend payout ratio is currently 62.55%.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Foundations Investment Advisors LLC boosted its stake in shares of Exelon by 3.5% during the third quarter. Foundations Investment Advisors LLC now owns 7,533 shares of the company’s stock valued at $305,000 after purchasing an additional 255 shares during the period. Harbor Capital Advisors Inc. boosted its position in Exelon by 1.0% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 28,392 shares of the company’s stock valued at $1,151,000 after buying an additional 274 shares during the period. Black Diamond Financial LLC grew its holdings in Exelon by 2.0% in the 2nd quarter. Black Diamond Financial LLC now owns 14,067 shares of the company’s stock worth $487,000 after acquiring an additional 279 shares during the last quarter. Ballentine Partners LLC raised its stake in shares of Exelon by 2.1% during the third quarter. Ballentine Partners LLC now owns 13,922 shares of the company’s stock valued at $565,000 after acquiring an additional 285 shares during the last quarter. Finally, Aptus Capital Advisors LLC boosted its holdings in shares of Exelon by 3.3% during the second quarter. Aptus Capital Advisors LLC now owns 9,412 shares of the company’s stock worth $326,000 after purchasing an additional 304 shares during the period. 80.92% of the stock is owned by hedge funds and other institutional investors.
Exelon Company Profile
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Articles
- Five stocks we like better than Exelon
- What Is WallStreetBets and What Stocks Are They Targeting?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Insider Trades May Not Tell You What You Think
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Special Dividend?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.